Preparation and Evaluation of Sildenafil Rapidly Disintegrating Tablets

DOI:

https://doi.org/10.37285/ijpsn.2012.5.1.4

Authors

  • Adel M Aly
  • A A Mohammed

Abstract

Sildenafil citrate is an oral therapy for erectile dysfunction (ED).  Sildenafil, a selective inhibitor of cyclic guanosine monophosphate-specific phosphodiesterase type 5 (PDE5), has been reported to be effective in men with ED associated with diabetes and prostate cancer, and in psychogenic ED.  The main objective of this study is to prepare more effective, rapidly disintegrating and rapid onset of action sildenafil oral tablets. Sildenafil tablets were prepared using the newly introduced Pharmaburst® as a direct compression vehicle in comparison with the well-known excipients, namely mannitol, anhydrous lactose and primojel. The formula containing Pharmaburst® showed the most rapidly-disintegrating effect (15 sec) compared to the other formulations. Thus, Pharmaburst® can be utilized as an effective direct compression vehicle as well as a superdisintegrant with very rapid disintegration time in vitro and in the oral cavity. The rapidly-disintegrating sildenafil tablets showed maximum serum concentration within only two minutes (Cmax of 0.76 µg) by applying the tablets to the oral cavity of rabbits, whereas, the conventional sildenafil tablets have a comparatively lower Cmax (0.56µg) through about 45 minutes. 

 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Sildenafil, OD tablets, Pharmaburst, erectile dysfunction, rabbits

Downloads

Published

2012-05-31

How to Cite

1.
Aly AM, Mohammed AA. Preparation and Evaluation of Sildenafil Rapidly Disintegrating Tablets. Scopus Indexed [Internet]. 2012 May 31 [cited 2024 Dec. 22];5(1):1617-20. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/562

Issue

Section

Research Articles

References

Aly AM, Semreen M.and Mazen KQ (2005). Superdisintegrants for solid dispersion to produce rapidly disintegrating tenoxicam tablets via camphor sublimation. Pharma Tech 29: 68-75.

Aly AM (2008). Preparation of rapidly disintegrating glipizide tablets by surface solid dispersion through superdisintegrants. Int J Pharm Sci Nanotech 1(3): October - December.

Aly AM (2003). Preparation of Rapidly Disintegrating Ketorolac Tromethamine Tablets by Direct compression and Lyophilizaion, Arab J Pharm Sci 2(4):47-60.

Aly AM, Bassam I, Amro and El Hajji FD (2011). Preparation and evaluation of rapidly disintegrating glimepiride tablets. Int J Pharm Sci Nanotech 3(4): January – March.

Aly AM and Aly AS (2010). Preparation and evaluation of glypizide tablets containing both enhanced and sustained release solid dispersions. Int J Pharm Sci Nanotech 2(4): January – March.

Bi YX, Sunada H, Yonezawa Y and Danjo K (1999). Evaluation of rapidly disintegrating tablets prepared by direct compression method, Drug Dev Ind Pharm 25(5),571-581.

Bi YX, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K (1996). Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 44:2121-2127.

Bix, Sunada H, Yonezawa Y and Dango K (1999). Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Development and Industrial Pharmacy 25:571-81.

Clarke K (2001). Breaking New Ground in Lyophilization. Life Science Today 2: 150-155.

Ishikawa T, Watanabe Y, Utoguchi N, Matsumoto M (1999). Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method. Chem Pharm Bull 47(10): 1451-1454.

Jennings T and Duan H (1995).Calorimetric Monitoring of Lyophilization. J Parental Sci Tech 49:272-82.

Koizumi KI, Watanabe Y, Morita K, Utoguchi N, and Matsumoto M (1997). New method of preparing high- porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharmaceutics 152: 127-131.

Mallet L (1996). Caring for the elderly patient. J. Am Pharm Assoc, 36 (11), 628.

Martindale (2009). The Complete Drug Reference, 36th Edition, Sean C. Sweetman, Pharmaceutical Press.

Ridwan Shabsigh, Joel Kaufman, Michelle Magee, Dana Creanga, David Russell and Meeta Budhwani A (2010). Multicenter, double-blind, placebo-controlled trial to assess the efficacy of sildenafil citrate in men with unrecognized erectile dysfunction. Urology 76: 373-379.

Safarinejad MR, Shafiei NS and Safarinejad (2010). An open label, randomized, fixed-dose, crossover study comparing efficacy and safety of sildenafil citrate and saffron (Crocus Sativus Linn.) for treating erectile dysfunction in men naïve to treatment. Int J Impotence Res 22: 240-250.

Sallam, E., Ibrahim, H., Dahab, R.A., Shubair, M., Khalil, E. (1998). Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant. Drug Dev Ind Pharm 24:501-507.

Stroberg, P, Kaminetsky, JC, Park , NC, Goldfischer, ER, Creanga, DL and Stecher, V.J. (2010). Hardness, function, emotional well-being, satisfaction and the overall sexual experience in men using 100-mg fixed-dose or flexible-dose sildenafil citrate. International Journal of Impotence Research 22, 284–289.

Sugihara (1995). New oral dosage form for elderly patient. Chem Pharm Bull 43(12): 1853-1861.

Stecher VJ, Jackson G, Banks I, Arver S and Greenall W (2010). Analysis of Pharmaceuticals Seized by Authorities in the United Kingdom for Suspicion of Being Counterfeit VIAGRA® (Sildenafil Citrate). Journal of Men's Health 7(3): 321.

Watanabe Y, Koizumi K, Zama Y, Kiriyama M, Matsumoto Y, Matsumoto M (1995). New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull 18: 1308-1310.